In addition, recent studies have shown that FGD4 expression in prostate cancer clinical samples is significantly up-regulated compared with the normal group, and down-regulation expression of FGD4 in prostate cancer cell lines can cause cell cycle arrest and proliferation reduction [28]. Here, FGD4 is linked to prostate cancer.